reviewTop 1% cited
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Hepatology · 2015 · Vol. 64(1) · pp. 73–84
Zobair M. Younossi✉(Inova Fairfax Hospital)Aaron B. Koenig(Inova Health System)Dinan Abdelatif(Inova Health System)Yousef Fazel(Inova Health System)Linda Henry(Center for Outcomes Research in Liver Diseases)Mark Wymer(Inova Health System)
Abstract
As the global epidemic of obesity fuels metabolic conditions, the clinical and economic burden of NAFLD will become enormous. (Hepatology 2016;64:73-84).
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsPancreatitis Pathology and TreatmentMedicineInternal medicineNonalcoholic fatty liver diseaseMetabolic syndromeEpidemiologyGastroenterologyIncidence (geometry)Fatty liverPopulationCirrhosis
MeSH terms
HumansObesityComorbidityIncidencePrevalenceDisease ProgressionNon-alcoholic Fatty Liver Disease
Citations
10,578
FWCI
229.21
field-weighted impact
References
31
Percentile
100%
vs. same field & year
Citations per year
Cited by
Knowledge about non-alcoholic fatty liver disease among family physician in primary health center at prince sultan medical military city, 2020
International Journal of Advanced Community Medicine · 2021 · 0 citations
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Hepatology · 2018 · 4,515 citations
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Journal of Hepatology · 2024 · 1,354 citations
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Hepatology · 2023 · 2,046 citations
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
International Journal of Molecular Sciences · 2019 · 1,518 citations
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Cells · 2020 · 1,137 citations
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
Hepatology · 2017 · 1,846 citations
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Hepatology · 2016 · 1,268 citations
References
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Alimentary Pharmacology & Therapeutics · 2011 · 3,085 citations
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Hepatology · 2012 · 3,804 citations
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Gastroenterology · 2015 · 2,900 citations
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
Journal of Hepatology · 2004 · 910 citations
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Gastroenterology · 2014 · 1,809 citations
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
Hepatology · 2014 · 2,228 citations
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Digestive Diseases and Sciences · 2013 · 298 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.